144 related articles for article (PubMed ID: 24497809)
1. Von Hippel-Lindau syndrome: demonstration of entire disease spectrum with (68)Ga-DOTANOC PET-CT.
Sharma P; Dhull VS; Bal C; Malhotra A; Kumar R
Korean J Radiol; 2014; 15(1):169-72. PubMed ID: 24497809
[TBL] [Abstract][Full Text] [Related]
2. 68Ga DOTANOC PET/CT aiding in the diagnosis of von Hippel-Lindau syndrome by detecting cerebellar hemangioblastoma and adrenal pheochromocytoma.
Mukherjee A; Karunanithi S; Bal C; Kumar R
Clin Nucl Med; 2014 Oct; 39(10):920-1. PubMed ID: 24999687
[TBL] [Abstract][Full Text] [Related]
3. 68 Ga-DOTANOC PET/CT in 2 Siblings With Von Hippel-Lindau Disease.
G B P; Damle NA; Reddy K R; Tandon N; Naranje P; Kandasamy D; Subudhi K
Clin Nucl Med; 2024 Jun; 49(6):e266-e268. PubMed ID: 38537203
[TBL] [Abstract][Full Text] [Related]
4. Incidental Detection of Viral Conjunctivitis on 68Ga-DOTANOC PET/CT in a Patient Suspected With Von Hippel-Lindau Syndrome.
Mathur Y; Krishnaraju VS; Singh H; Kumar R; Dutta P
Clin Nucl Med; 2022 May; 47(5):e408-e410. PubMed ID: 35195580
[TBL] [Abstract][Full Text] [Related]
5. 68Ga-DOTA-NOC PET/CT detects somatostatin receptors expression in von hippel-lindau cerebellar disease.
Ambrosini V; Campana D; Allegri V; Opocher G; Fanti S
Clin Nucl Med; 2011 Jan; 36(1):64-5. PubMed ID: 21157217
[TBL] [Abstract][Full Text] [Related]
6. Kidney Tumor in a von Hippel-Lindau (VHL) Patient With Intensely Increased Activity on 68Ga-DOTA-TATE PET/CT.
Papadakis GZ; Millo C; Sadowski SM; Bagci U; Patronas NJ
Clin Nucl Med; 2016 Dec; 41(12):970-971. PubMed ID: 27749408
[TBL] [Abstract][Full Text] [Related]
7. 68Ga-DOTA-TOC PET/CT of von Hippel-Lindau Disease.
Liberini V; Nicolotti DG; Maccario M; Finessi M; Deandreis D
Clin Nucl Med; 2019 Feb; 44(2):125-126. PubMed ID: 30516678
[TBL] [Abstract][Full Text] [Related]
8. The utility of
Shell J; Tirosh A; Millo C; Sadowski SM; Assadipour Y; Green P; Patel D; Nilubol N; Kebebew E
Eur J Radiol; 2019 Mar; 112():130-135. PubMed ID: 30777201
[TBL] [Abstract][Full Text] [Related]
9. Al18F-NOTA-Octreotide PET/CT and 18F-FDG PET/CT for Detecting Cerebellar Hemangioblastoma in a Patient With Von Hippel-Lindau Disease.
Hou G; Cheng X; Chi Y; Wang X; Zheng R
Clin Nucl Med; 2024 Mar; 49(3):289-291. PubMed ID: 38306383
[TBL] [Abstract][Full Text] [Related]
10. 18F-FDG and 68Ga-DOTATATE PET/CT in von Hippel-Lindau Disease-Associated Retinal Hemangioblastoma.
Papadakis GZ; Millo C; Jassel IS; Bagci U; Sadowski SM; Karantanas AH; Patronas NJ
Clin Nucl Med; 2017 Mar; 42(3):189-190. PubMed ID: 28033220
[TBL] [Abstract][Full Text] [Related]
11. Suprasellar Hemangioblastoma on 68 Ga-DOTATATE PET/CT.
Filizoglu N; Ozguven S
Clin Nucl Med; 2022 Nov; 47(11):e700-e701. PubMed ID: 35695763
[TBL] [Abstract][Full Text] [Related]
12. Constellation of Von Hippel-Lindau Disease-Related Findings on a 68Ga-DOTATATE PET/CT.
Marcus C; John PD; Giles M; Sethi I
Clin Nucl Med; 2021 Oct; 46(10):829-831. PubMed ID: 34028413
[TBL] [Abstract][Full Text] [Related]
13. Von Hippel-Lindau disease: a radiological essay.
Torreggiani WC; Keogh C; Al-Ismail K; Munk PL; Nicolaou S
Clin Radiol; 2002 Aug; 57(8):670-80. PubMed ID: 12169278
[TBL] [Abstract][Full Text] [Related]
14. 68Ga DOTATATE PET/CT Versus 18F-FDG PET/CT for Detecting Intramedullary Hemangioblastoma in a Patient With Von Hippel-Lindau Disease.
Banezhad F; Kiamanesh Z; Emami F; Sadeghi R
Clin Nucl Med; 2019 Jun; 44(6):e385-e387. PubMed ID: 30985433
[TBL] [Abstract][Full Text] [Related]
15. Epididymal Cystadenomas in von Hippel-Lindau Disease Showing Increased Activity on 68Ga DOTATATE PET/CT.
Papadakis GZ; Millo C; Sadowski SM; Bagci U; Patronas NJ
Clin Nucl Med; 2016 Oct; 41(10):781-2. PubMed ID: 27454594
[TBL] [Abstract][Full Text] [Related]
16. FDG PET/CT detects clinically occult pancreatic cancer in a case of Von Hippel-Lindau syndrome.
Kulkarni M; Purandare N; Zade A; Agrawal A; Shah S; Rangarajan V
Clin Nucl Med; 2013 Jul; 38(7):e302-3. PubMed ID: 23486326
[TBL] [Abstract][Full Text] [Related]
17. Potential role of (68)Ga-DOTATOC PET/CT in screening for pancreatic neuroendocrine tumour in patients with von Hippel-Lindau disease.
Prasad V; Tiling N; Denecke T; Brenner W; Plöckinger U
Eur J Nucl Med Mol Imaging; 2016 Oct; 43(11):2014-20. PubMed ID: 27293206
[TBL] [Abstract][Full Text] [Related]
18. 89Zr-Bevacizumab PET Visualizes Disease Manifestations in Patients with von Hippel-Lindau Disease.
Oosting SF; van Asselt SJ; Brouwers AH; Bongaerts AH; Steinberg JD; de Jong JR; Lub-de Hooge MN; van der Horst-Schrivers AN; Walenkamp AM; Hoving EW; Sluiter WJ; Zonnenberg BA; de Vries EG; Links TP
J Nucl Med; 2016 Aug; 57(8):1244-50. PubMed ID: 27173161
[TBL] [Abstract][Full Text] [Related]
19. CT diagnosis of unsuspected von Hippel-Lindau disease.
Kuhlman JK; Fishman EK; Marshall FF; Siegelman SS
Urology; 1987 Nov; 30(5):505-8. PubMed ID: 3672691
[TBL] [Abstract][Full Text] [Related]
20. Different manifestations detected with 68Ga-DOTATOC PET/CT in patients with Von Hippel-Lindau disease: A case report.
Meneret P; Girard A; Pagenault M; Riffaud L; Palard-Novello X
Nuklearmedizin; 2020 Aug; 59(4):332-334. PubMed ID: 32193881
[No Abstract] [Full Text] [Related]
[Next] [New Search]
